Literature DB >> 409121

Ultrasonic evaluation of the obstructed duplex kidney.

V J Mascatello, E H Smith, G F Carrera, M Berger, R L Teele.   

Abstract

The problem of a duplex collecting system associated with an obstructed ectopic ureter or ureterocele is common in pediatric urology. Four such patients were studied by gray scale ultrasound which was useful in demonstrating the dilated upper pole collecting system as well as an ectopic ureter and a ureterocele. Although the diagnosis of a nonfunctioning upper pole unit in a duplex kidney is usually suggested by the urogram, ultrasound provides a noninvasive means of confirmation which is independant of function. Further, ultrasound-guided puncture with antegrade pyelography demonstrates the course of the ectopic ureter, thus providing a more complete preoperative evaluation.

Entities:  

Mesh:

Year:  1977        PMID: 409121     DOI: 10.2214/ajr.129.1.113

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Ultrasound diagnosis of ectopic ureterocele.

Authors:  J S Rose; J McCarthy; H C Yeh
Journal:  Pediatr Radiol       Date:  1979-02-26

2.  A review of the ultrasonic appearances of posterior urethral valve and ureteroceles.

Authors:  B J Cremin
Journal:  Pediatr Radiol       Date:  1986

Review 3.  Ultrasonographic anatomy and diagnosis of fetal uropathies affecting the upper urinary tract. I. Obstructive uropathies.

Authors:  J M Duval; J Milon; Y Coadou; J M Blouet; B Langella; T Bourgin; J C Nicolas; B Fremond; J C Duval; H Jouan
Journal:  Anat Clin       Date:  1985

4.  Is renal ultrasound a reliable indicator of a nonobstructed duplication anomaly?

Authors:  J G Horgan; N S Rosenfield; R M Weiss; A T Rosenfield
Journal:  Pediatr Radiol       Date:  1984

5.  Acute nondilated anuric obstructive nephropathy on echography: difficult diagnosis in the intensive care unit.

Authors:  C Charasse; C Camus; P Darnault; F Guillé; Y le Tulzo; F Zimbacca; R Thomas
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.